✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Hemp ProductsProduct QualitySupply ChainNutritionAgriculture Why This MattersHemp seed oil production models directly impact...
In the Mix: 7 More Articles โ April 14, 2026
In the Mix โ Last 24 HoursApril 14, 2026. 7 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25CATHAROS launches: Germany's local marketplace for...
Federal Judge Halts Rhode Island’s Cannabis Dispensary Expansion – Providence Today
✦ New CED Clinical Relevance #82High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic AccessLegalPolicyPatient CareSupply Why This MattersLegal disruptions to cannabis dispensary access directly impact patient...
Markets ‘completely wrong’ on Iran war, oil could hit $200 a barrel: Economist – YouTube
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Supply ChainPatient AccessAnxietyEconomic ImpactHealthcare Policy Why This MattersOil price volatility and geopolitical instability can...
Ascend and NuProject Launch ROOTS Program to Prepare Cannabis Businesses for …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Supply ChainProduct QualityIndustry StandardsAccessPolicy Why This MattersAs cannabis transitions from state-regulated markets to potential...
OCM issues precautionary recall for select cannabis products tested by Keystone Lab – CBS 6 Albany
WHY IT MATTERS: Patients relying on tested and labeled cannabis products from New York dispensaries should check the OCM recall list to confirm their specific products are safe to use and return any flagged items to their point of purchase. CLINICAL OVERVIEW: Regulatory bodies like the New York State Office of Cannabis Management have the authority to issue precautionary recalls when questions arise about the accuracy or integrity of third-party laboratory testing, which serves as the primary safety checkpoint between cultivators and consumers. Cannabis testing laboratories are responsible for verifying potency, pesticide levels, heavy metals, residual solvents, and microbial contamination, and any uncertainty in those results can expose patients and consumers to unquantified risks.